Adaptive Stock Based Compensation from 2010 to 2025

ADPT Stock  USD 8.26  0.10  1.23%   
Adaptive Biotechnologies Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2018-03-31
Previous Quarter
13 M
Current Value
13.5 M
Quarterly Volatility
5.1 M
 
Covid
Check Adaptive Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adaptive Biotechnologies' main balance sheet or income statement drivers, such as Interest Income of 16.3 M, Discontinued Operations of 0.0 or Depreciation And Amortization of 13.1 M, as well as many indicators such as Price To Sales Ratio of 4.54, Dividend Yield of 0.0 or PTB Ratio of 2.17. Adaptive financial statements analysis is a perfect complement when working with Adaptive Biotechnologies Valuation or Volatility modules.
  
Check out the analysis of Adaptive Biotechnologies Correlation against competitors.

Latest Adaptive Biotechnologies' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Adaptive Biotechnologies Corp over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Adaptive Biotechnologies' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Adaptive Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation10 Years Trend
Slightly volatile
   Stock Based Compensation   
       Timeline  

Adaptive Stock Based Compensation Regression Statistics

Arithmetic Mean25,940,476
Geometric Mean15,947,612
Coefficient Of Variation101.73
Mean Deviation22,529,904
Median11,149,000
Standard Deviation26,389,019
Sample Variance696.4T
Range69M
R-Value0.88
Mean Square Error174.3T
R-Squared0.77
Slope4,852,476
Total Sum of Squares10445.7T

Adaptive Stock Based Compensation History

202576 M
202472.3 M
202362.9 M
202255.5 M
202143.3 M
202024.8 M
201913.1 M

Other Fundumenentals of Adaptive Biotechnologies

Adaptive Biotechnologies Stock Based Compensation component correlations

0.990.980.980.52-0.650.6-0.40.58-0.290.930.930.89-0.920.990.630.970.93-0.750.920.680.93
0.990.990.990.54-0.690.64-0.380.6-0.260.920.940.92-0.941.00.630.950.91-0.790.950.730.95
0.980.990.980.62-0.750.72-0.390.66-0.270.90.960.96-0.970.990.580.940.89-0.850.980.790.98
0.980.990.980.57-0.730.65-0.410.64-0.290.860.950.93-0.950.990.650.910.85-0.820.960.790.96
0.520.540.620.57-0.930.82-0.810.93-0.750.490.780.74-0.750.54-0.120.520.46-0.880.730.770.76
-0.65-0.69-0.75-0.73-0.93-0.910.63-0.960.54-0.57-0.86-0.880.84-0.69-0.06-0.61-0.530.97-0.86-0.93-0.87
0.60.640.720.650.82-0.91-0.470.91-0.380.610.80.86-0.780.64-0.060.640.57-0.920.830.880.83
-0.4-0.38-0.39-0.41-0.810.63-0.47-0.740.99-0.37-0.61-0.450.56-0.380.12-0.39-0.360.56-0.47-0.42-0.52
0.580.60.660.640.93-0.960.91-0.74-0.670.540.820.8-0.780.6-0.10.580.51-0.910.780.840.8
-0.29-0.26-0.27-0.29-0.750.54-0.380.99-0.67-0.26-0.5-0.320.45-0.260.19-0.28-0.260.45-0.35-0.32-0.4
0.930.920.90.860.49-0.570.61-0.370.54-0.260.860.81-0.820.920.40.991.0-0.670.850.530.85
0.930.940.960.950.78-0.860.8-0.610.82-0.50.860.96-0.990.940.410.90.84-0.920.980.830.99
0.890.920.960.930.74-0.880.86-0.450.8-0.320.810.96-0.960.920.410.850.79-0.951.00.920.99
-0.92-0.94-0.97-0.95-0.750.84-0.780.56-0.780.45-0.82-0.99-0.96-0.94-0.49-0.87-0.810.9-0.98-0.83-0.99
0.991.00.990.990.54-0.690.64-0.380.6-0.260.920.940.92-0.940.630.950.91-0.790.950.730.95
0.630.630.580.65-0.12-0.06-0.060.12-0.10.190.40.410.41-0.490.630.460.43-0.190.450.270.43
0.970.950.940.910.52-0.610.64-0.390.58-0.280.990.90.85-0.870.950.460.99-0.720.890.60.89
0.930.910.890.850.46-0.530.57-0.360.51-0.261.00.840.79-0.810.910.430.99-0.640.830.50.83
-0.75-0.79-0.85-0.82-0.880.97-0.920.56-0.910.45-0.67-0.92-0.950.9-0.79-0.19-0.72-0.64-0.93-0.96-0.94
0.920.950.980.960.73-0.860.83-0.470.78-0.350.850.981.0-0.980.950.450.890.83-0.930.881.0
0.680.730.790.790.77-0.930.88-0.420.84-0.320.530.830.92-0.830.730.270.60.5-0.960.880.88
0.930.950.980.960.76-0.870.83-0.520.8-0.40.850.990.99-0.990.950.430.890.83-0.941.00.88
Click cells to compare fundamentals

About Adaptive Biotechnologies Financial Statements

Adaptive Biotechnologies shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Adaptive Biotechnologies investors may analyze each financial statement separately, they are all interrelated. The changes in Adaptive Biotechnologies' assets and liabilities, for example, are also reflected in the revenues and expenses on on Adaptive Biotechnologies' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation72.3 M76 M
Stock Based Compensation To Revenue 0.33  0.20 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Adaptive Stock Analysis

When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.